🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Thyme Care

2 posts
Read More

Thyme Care crosses $2bn valuation as $7bn oncology platform expands into new businesses

Thyme Care has secured more than $125 million from Morgan Health, Humana, CVS Health Ventures and other investors at a valuation above $2 billion. The company is already profitable, reaches 10.5 million people and manages more than $7 billion of oncology spending. Its next move is more ambitious: turning the cancer-care platform into a parent company that can attack drug costs, biosimilar adoption and clinical-trial access.